Company Presentation • 30 Oct 2024 05:00
Company Presentation • 07 Aug 2024 05:00
Company Presentation • 01 May 2024 05:00
Company Presentation • 07 Feb 2024 06:00
Company Presentation • 12 Dec 2023 22:00
ENTITY
Exelixis Inc (EXEL US)
Exelixis Inc (EXEL US)
16
Analysis
Health Care • United States
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
more
x